Beth Burgwyn Fuchs

Papers

Total Citations

H-Index

About

Beth Burgwyn Fuchs is a pioneering researcher in antimicrobial drug discovery and infectious disease biology, with a focus on combating multidrug-resistant pathogens. Her most cited work, "Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus" (2014, 99 citations), revolutionized high-throughput screening by adapting the *Caenorhabditis elegans*–*S. aureus* infection model to an automated liquid-based platform. This innovation enabled rapid, whole-organism testing of compounds against methicillin-resistant *Staphylococcus aureus* (MRSA), bridging the gap between in vitro assays and mammalian models. By leveraging the nematode’s genetic tractability and the pathogen’s clinical relevance, Fuchs demonstrated that automated survival assays could identify novel anti-infectives while assessing host toxicity—a critical advance for preclinical drug development. Her work has been widely cited for its methodological impact, accelerating the discovery of therapies for hospital-acquired infections. Beyond this flagship study, Fuchs has contributed to understanding host-pathogen interactions and resistance mechanisms, cementing her role as a key figure in translational infectious disease research.